Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing.
Samsung Life Science Fund, an investment fund created by Samsung affiliates, will invest in Latus Bio, a US gene therapy development company, according to Samsung Bioepis on Friday. It is the sixth investment made by the fund between Samsung Biologics, Samsung C&T and Samsung Bioepis, to explore new business opportunities in the biotechnology sector. The exact amount of investment has not been disclosed. Latus Bi.
How a Pa. Wilds remote worker enticement program measures success wesa.fm - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wesa.fm Daily Mail and Mail on Sunday newspapers.
Thousands of public dollars have gone toward the Wilds Are Working program. While only one participant has decided to move to the area, organizers say the program has other markers